Header image

Transforming Global Genetic Data into Medical Decisions

Our goal is the rapid medical diagnosis of inherited diseases, provided at the earliest possible moment as we turn analytical information into actionable results for physicians, patients and pharmaceutical partners.

Our commitment to the global medical community is an early and precise diagnosis for continuous improvement of therapeutic options for each individual patient.

Latest Scientific News

Genotype Phenotype Correlation in a New Fabry-Disease-Causing Mutation

The interpretation of missense variants in a disease context is challenging, especially…

A hexanucleotide repeat modifies expressivity of X-linked dystonia…

Disease expressivity varies widely in many genetic disorders, and identifying the…

Identification of PKD1 and PKD2 gene variants in a cohort of 125 Asian…

CENTOGENE considers its global positioning a key aspect for generating truly novel…

A homozygous frameshift variant in an alternatively spliced exon of DLG5…

Based on the ambition to provide maximum diagnostic yield, CENTOGENE offers follow up of…

Customer Feedback

Give feedback

Newsletter subscription

 CENTOGENE today welcomed Germany’s Chancellor Dr. Angela Merkel to its headquarters together with Manuela Schwesig, Minister-President of...

Read more

Digitalisierung - was braucht das Land und was braucht die Wirtschaft am Beispiel einer Erfolgsgeschichte der Branche Gesundheitswirtschaft

Read more

Research Fellow from German Research Center for Artificial Intelligence to lead team driving solutions for pharmaceutical partners.

Read more

Combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions.

Read more

CENTOGENE announced today that Dr. Flemming Ornskov has been appointed to the Supervisory Board and has been elected Non-Executive Chairman.  His appointment is...

Read more

As part of an exchange with senior business and academic leaders, and state of Mecklenburg-Vorpommern (M-V) government representatives, a discussion and...

Read more

Agreement focused on identification of patients with Duchenne muscular dystrophy (DMD)

Read more

CENTOGENE, a rare disease company committed to improving the lives of rare disease patients by providing solutions that accelerate the development of drugs, has...

Read more

Driving Pharmaceutical Partnerships and Accelerating Orphan Drug Development

Read more